Global Blood Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GBT and buy or sell other stocks, ETFs, and their options commission-free!About GBT
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases.
CEOBert Bruce
CEOBert Bruce
Employees—
Employees—
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2011
Founded2011
Employees—
Employees—
GBT Key Statistics
Market cap4.62B
Market cap4.62B
Price-Earnings ratio-13.70
Price-Earnings ratio-13.70
Dividend yield—
Dividend yield—
Average volume2.06M
Average volume2.06M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$73.02
52 Week high$73.02
52 Week low$21.65
52 Week low$21.65
Stock Snapshot
As of today, Global Blood Therapeutics(GBT) shares are valued at $68.49. The company's market cap stands at 4.62B, with a P/E ratio of -13.70.
On 2025-11-10, Global Blood Therapeutics(GBT) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 2.06M.
The stock's 52-week range extends from a low of $21.65 to a high of $73.02.
The stock's 52-week range extends from a low of $21.65 to a high of $73.02.
People also own
Based on the portfolios of people who own GBT. This list is generated using Robinhood data, and it’s not a recommendation.